UK Researchers Say Methadone and Buprenorphine Reduce Mortality by 85%
Researchers in Bristol and London compared the mortality rates of opiate users involved in an opiate substitution program (using methadone or buprenorphine) with the mortality rates of opiate users not involved in a treatment program.
They found that:
- People who stayed involved in an opiate treatment program for 12 months or longer were 85% less likely to die in any given period than opiate users not involved in a treatment program
- During a period of opiate substitution treatment, the most risky periods are the first few weeks of treatment and the first month after the end of treatment. During the first few weeks, the rate of death was almost 3 times higher than during the rest of the treatment period. In the month immediately after the end of treatment, the death rate was 8 or 9 times the rate observed during the period of stable treatment.
The full research results on opiate substitution program mortality can be read in BMJ.
John Lee
Post a comment 0
Copyright Notice
We welcome republishing of our content on condition that you credit Choose Help and the respective authors. This article is licensed under a Creative Commons License.
Helpful Reading:
-
Comparing Zubsolv with Suboxone
Zubsolv is a new drug for opiate dependence. Like Suboxone, it’s composed of a combination of buprenorphine and naloxone. Read on to learn about how it works and how it differs from Suboxone.
Read the complete article -
Getting High on Suboxone?
Users taking Suboxone to stave off the withdrawal pains of an opiate addiction aren't supposed to be able to abuse the medication. That was the idea anyway when the FDA approved the drug in 2002 for take-home use. Today's thriving street market for the drug has the FDA change its tune.
Read the complete article
